StonvexLoading…
StonvexStonvexStonvexCore line items from VRCA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $7.57M | $5.12M | $9.03M | $12.00M |
Operating Income | $-65.92M | $-65.76M | $-21.30M | $-30.91M |
Net Income | $-76.58M | $-67.00M | $-24.49M | $-35.08M |
EPS (Diluted) | $-14.78 | $-1.48 | $-0.72 | $-1.30 |
Total Assets | $54.13M | $81.60M | $44.72M | $80.13M |
Total Liabilities | $63.99M | $61.83M | $4.69M | $47.52M |
Cash & Equivalents | $46.33M | $69.55M | $34.27M | $15.75M |
Free Cash Flow OCF − CapEx | $-60.95M | $-38.94M | $-18.95M | $-28.46M |
Shares Outstanding | 9.18M | 42.41M | 41.09M | 27.52M |